Location: Home
  • search
  • go
  • Relate News
  • 1/6/2010China Aoxing Pharma completes phase II trials of novel PD drug
  • 1/5/2010More details emerge on the negotiation mechanism of the NDRL
  • 1/4/2010MOH to introduce plan for public hospital reform trials soon
  • 1/4/2010MOC takes over industry administration of the Chinese pharma distribut...
  • 1/4/2010MOH issues clinical pathways for two blood diseases
  • 12/30/2009MOH introduces clinical guidelines and formulary for essential drugs ...
  • 12/30/2009MSD cuts price of Zocor for higher market share
  • 12/30/2009Ranbaxy sells majority stake in Guangzhou JV to HNG Chembio
  • 12/29/2009Sinovac files application for HFMD vaccine with the SFDA
  • 12/25/2009MSD expects China business to grow 20% annually in the near future
  • 12/25/2009CFO change at China Medicines
  • 12/23/2009Chi-Med ties up with Cambridge for research into active ingredients of...
  • 12/23/2009Returns on R&D investments of MNCs questioned as Pfizer cuts resea...
  • 12/23/2009SinoPharm denies bid for Ratiopharm
  • 12/23/2009Chinese and Singaporean scientists identify leprosy genes
  • 12/22/2009Essential drug objectives likely to be delayed
  • 12/22/2009CNIG to reorganize Hubei Pharmaceutical
  • 12/17/2009Pfizer deepens research collaboration with Peking University
  • 12/17/2009AlphaRx signs API supply agreement with VenturePharm
  • 12/17/2009Rivalry intensifies in China for monoclonal antibody drugs
  • 12/15/2009PwC: Personalized Medicine Market To Grow 11% Annually
  • 12/15/2009Chinese hospital market growth slowed in the first half of 2009
  • 12/15/2009Simcere Pharma enters strategic alliance with TigerMed
  • 12/15/2009Emerging Drug Delivery Systems for the Development of Biopharmaceutica...
  • 12/14/2009Nanjing Pharma acquires pharmacy service company from parent company ...
  • 12/11/2009Agios Pharma and Shanghai ChemPartner reports groundbreaking cancer re...
  • 12/10/2009Roche to invest US$72M for translational research in Singapore
  • 12/10/2009Instem establishes office in Shanghai
  • 12/10/2009Merck KGaA initiates phase III trials of therapeutic cancer vaccine in...
  • 12/10/2009Survey finds China key for global profitability
  • Page:317/355 Total number of articles:10627: [First][<<] [315] [316] [317] [318] [319] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group